產(chǎn)品名稱

AM 281

產(chǎn)品貨號

Axon 1219 CAS [202463-68-1] MF C21H19Cl2IN4O2MW 557.21 Purity: 99% Soluble in DMSO Description Potent and selective CB1 cannabinoid receptor antagonist/inverse agonist References Certificates Categories Extra info F Molina-Holgado et al. Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling. Mol. Cell. Neurosci. 2005, 28, 189-194. ? AN Gifford et al. Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices. Neurosci. Lett. 1997,? 238, 84-86. Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS Diabetes & Metabolism Pain & Inflammation CB1 A13 CB1 antagonist Chemical name 1-(2,4-Dichloro-phenyl)-5-(4-iodo-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid morpholin-4-ylamide Parent CAS No. [202463-68-1] Order Size Unit Price Stock 10 mg €95.00 In Stock

產(chǎn)品價格

現(xiàn)貨詢價，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

AM 281

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 1219

CAS [202463-68-1]

MF C21H19Cl2IN4O2
MW 557.21

Purity: 99%
Soluble in DMSO

AM 281

Description

Potent and selective CB1 cannabinoid receptor antagonist/inverse agonist

F Molina-Holgado et al. Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling. Mol. Cell. Neurosci. 2005, 28, 189-194.

AN Gifford et al. Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices. Neurosci. Lett. 1997,? 238, 84-86.

Certificate of Analysis
Material Safety Data Sheet

Cardiovascular CNS Diabetes & Metabolism Pain & Inflammation CB1 A13

CB1 antagonist

Chemical name

1-(2,4-Dichloro-phenyl)-5-(4-iodo-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid morpholin-4-ylamide

Parent CAS No.

[202463-68-1]

產(chǎn)品資料